CDC advisers recommend Covid vaccine boosters for kids & adults

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 63%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

A Centers for Disease Control advisory panel is recommending adults and children older than six months get the latest Covid vaccine booster shots. The panel approved the vaccines from Pfizer (PFE) and Moderna (MRNA). Novavax (NVAX) is still awaiting authorization from the U.S. Food and Drug Administration for its booster. Yahoo Finance Health Care Reporter Anjalee Khemlani explains the story. 

Best Movies of All Time That You Should Watch ImmediatelyStudents struggling in wake of pandemic, more mental health resources needed: Toronto board of health

More mental health resources are needed for child and teens still suffering negative impacts from the COVID-19 pandemic, Toronto's board of health says.The board decided at a meeting on Monday to recommend that the city ask the province for more mental health funding to help students who require "intensive" intervention that goes beyond the scope of the school system.

A report, released by Alberta Health Services Tuesday, details health violations at a shared kitchen used by a number of daycares in the city. This comes after an outbreak of the shiga toxin-producing E. coli, which can cause serious issues, at a number of daycares in Calgary. The outbreak has resulted in a number of children in hospital and on dialysis after developing hemolytic uremic syndrome, a disease which affects the kidneys.At a press conference Tuesday, Dr.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in FİNANCE

Finance Finance Latest News, Finance Finance Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Acelyrin tumbles after skin disease drug fails key trial(Reuters) - Shares of drug developer Acelyrin slumped 57% in premarket trading on Tuesday after the company's experimental lead drug failed to show it ...
Source: SaltWire Network - 🏆 45. / 63 Read more »